These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4450332)

  • 21. METABOLIC effecto of dihydrotachysterol.
    Nutr Rev; 1956 Jun; 14(6):176-7. PubMed ID: 13335022
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of aluminium hydroxide orally on calcium, phosphorus and aluminium metabolism in normal subjects.
    Cam JM; Luck VA; Eastwood JB; de Wardener HE
    Clin Sci Mol Med; 1976 Oct; 51(4):407-14. PubMed ID: 971581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of aluminum hydroxide on serum calcium, serum phosphorus and calcium turnover in uremic patients].
    Friis T; Weeke E
    Nord Med; 1969 Sep; 82(37):1136-42. PubMed ID: 5354523
    [No Abstract]   [Full Text] [Related]  

  • 24. Distortions of bone cell metabolism in uremia and their cause.
    Nichols G; Flanagan B; Veer Jv
    Arch Intern Med; 1969 Nov; 124(5):530-8. PubMed ID: 5345859
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomicroscopy of the anterior eye segment in chronic renal failure.
    Szmigielski M; Gradowska L; Komitowski D
    Pol Med J; 1970; 9(1):51-4. PubMed ID: 5437042
    [No Abstract]   [Full Text] [Related]  

  • 26. Observations on calcium metabolism, 47Ca absorption, and duodenal calcium-binding activity in chronic renal failure: studies in Beagles with radiation-induced nephropathy.
    Norrdin RW; Miller CW; LoPresti CA; Taylor AN; Arnold JS
    Am J Vet Res; 1980 Apr; 41(4):510-5. PubMed ID: 7406272
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of acute hypercalcemia on renal clearance of calcium and phosphorus in chronic uremia].
    Mioni G; Huber W; Bazzato G; D'Angelo A; Ossi E; Bertaglia E; Maschio G
    Minerva Nefrol; 1970; 17(3):75-82. PubMed ID: 5515029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Disturbances of calcium/phosphorus metabolism in chronic renal disease].
    Bohmer T
    Tidsskr Nor Laegeforen; 1974 Nov; 94(33):2320-6. PubMed ID: 4612872
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium requirements in humans. Report of original data and a review.
    Spencer H; Kramer L; Lesniak M; De Bartolo M; Norris C; Osis D
    Clin Orthop Relat Res; 1984 Apr; (184):270-80. PubMed ID: 6368085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of calcitonin on calcium-phosphorus homeostasis in patients with chronic renal insufficiency].
    Chiarini P; Matassi L; Fabrizi De Biani G
    Minerva Nefrol; 1975; 22(6):321-6. PubMed ID: 1223711
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcinosis cutis and renal failure.
    Kolton B; Pedersen J
    Arch Dermatol; 1974 Aug; 110(2):256-7. PubMed ID: 4850845
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intravenous amino acid infusion in chronic uremia].
    Josephson B; Bergström J; Bucht H; Dahlinder D; Fürst P; Hultman E; Norée LO; Vinnars E
    Nord Med; 1969 Jun; 81(25):770-7. PubMed ID: 4978846
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disseminated intravascular coagulation syndrome in glomerulonephritis].
    Shul'tsev GP; Panchenko VM; Bazgadze VM; Charnyĭ AM
    Klin Med (Mosk); 1981 Oct; 59(10):34-8. PubMed ID: 7311408
    [No Abstract]   [Full Text] [Related]  

  • 34. The early effects of dihydrotachysterol on calcium and phosphorus metabolism in patients with hypoparathyroidism.
    Hunt G; Morgan DB
    Clin Sci; 1970 Jun; 38(6):713-25. PubMed ID: 5431603
    [No Abstract]   [Full Text] [Related]  

  • 35. Some metabolic effects of a single dose of crystalline dihydrotachysterol.
    Burriss Garrett RJ; Bickley HC; Little JW
    Can J Physiol Pharmacol; 1972 Nov; 50(11):1086-90. PubMed ID: 4640802
    [No Abstract]   [Full Text] [Related]  

  • 36. Prerenal uremia in chronic renal diseases. II. Prerenal uremia due to hypovolemia.
    Orlowski Z
    Pol Med J; 1969; 8(4):846-52. PubMed ID: 5404478
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some characteristics of phosphorus-calcium metabolism and the bone system pathology in chronic uremia].
    Ermolenko VM; Nikiforova NV; Migunova NA; Bochman NL; Rassokhin BM
    Ter Arkh; 1973 May; 45(5):70-8. PubMed ID: 4768378
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of dietary calcium and phosphorus level upon calcium, phosphorus and nitrogen balance in swine.
    Vipperman PE; Peo ER; Cunningham PJ
    J Anim Sci; 1974 Apr; 38(4):758-65. PubMed ID: 4823185
    [No Abstract]   [Full Text] [Related]  

  • 39. Diet and dialysis patients--theory versus practice.
    Musselmann L
    Contrib Nephrol; 1985; 44():137-47. PubMed ID: 3987284
    [No Abstract]   [Full Text] [Related]  

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.